Oral therapy for pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A Controlled Trial of Trimethoprim—Sulfamethoxazole versus Trimethoprim—Dapsone

New England Journal of Medicine

Volumn 323, Issue 12, 1990, Pages 776-782

  Medina, Ileana ^a   Mills, John ^a   Leoung, Gifford ^a   Hopewell, Philip C ^a   Lee, Belle ^a   Modin, Gunnard ^a   Benowitz, Neal ^a   Wofsy, Constance B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DAPSONE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTOZOON; RASH; VOMITING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, ORAL; ADULT; COMPARATIVE STUDY; DAPSONE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HEPATITIS, TOXIC; HUMAN; MALE; NEUTROPENIA; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS CARINII; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0024997661     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199009203231202     Document Type: Article

References (28)

1. Selik RM, Statcher ET, Curran Jw. Opportunistic diseases reported in AIDS patients: frequencies, associations and trends. AIDS 1987; 1:175–82.
2. DeVita VT Jr, Broder S, Fauci AS, Kovacs JA, Chabner BA. Developmental therapeutics and the acquired immunodeficiency syndrome. Ann Intent Med 1987; 106:568–81.
3. Murray JF, Felton CP, Garay SM, et al. Pulmonary complications ot the acquired immunodeficiency syndrome: report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med 1984; 310:1682–8.
4. Update: acquired immunodeficiency syndrome—United States. MMWR 1986; 35:17–21.
5. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100:663–71.
6. Armstrong D, Gold JW, Diyjauski J, et al. Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann lntern Med 1985; 103:738–43.
7. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim—sulfarmethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100:495–9.
8. Jick H. Adverse reactions to trimethoprim–sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982; 4:426–8.
9. Wharton JM, Coleman DL, Wofsy CB, el al. Trimethoprim–sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective randomized trial. Ann Intern Med 1986; 105:37–44.
10. Hughes WT, Smith BL. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother 1984; 26:436–40.
11. Leoung GS, Mills J, Hopewell PC, Hughes W, Wofsy C. Dapsone-trimelhoprim for Pneumocystis carinii pneumonia in the acquired Immunodeficiency syndrome. Ann Intern Med 1986; 105:45–8.
12. Richardson S, Fanning M, Brunton J, et al. Diaminodiphenylsulfone (dapsone) as treatment for Pneumocystis carinii pneumonia in AIDS patients in combination with trimethoprim. In: Abstracts from the first International Conference on AIDS, Atlanta, April 14–17, 1985:25. abstract.
13. Mills J, Leoung G, Medina I, Hopewell PC, Hughes WT, Wofsy C. Dapsone treatment of Pneumocystis carinii pneumonia in die acquired immunodeficiency syndrome. Antimicrob Agents Chemolher 1988; 32:1057–60.
14. Haverkos HW. Assessment of therapy in Pneunocystis carinii pneumonia: PCP Therapy Project Group. Am J Med 1984; 76:501–8.
15. Sattler FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim–sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective noncrossover study. Ann Intern Med 1988; 109:280–7.
16. Bigby TD, Margolskee D, Curtis JL, et al. The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986; 133:515–8.
17. Broaddus VCL, Dake MD, Stulbarg MS, et al. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102:747–52.
18. Ng VL, Gartner I, Weymouth LA, Goodman CD, Hopcwell PC, Hadley WK. The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection. Arch Pathol Lab Med 1989; 113:488–93.
19. Lee BL, Medina I, Benowilz NL, Jacob P, Wofsy CB, Mills JV. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of pneumocystis pneumonia in patients with the acquired Immunodeficiency syndrome (AIDS): evidence of drug interactions. Ann Intern Med 1989; 110:606–11.
20. Coleman DL, Hattner RS, Luce JM, Dodek PM, Golden JA, Murray JF. Correlation between gallium lung scans and fiberoptic bronchoscopy in patients with suspected Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis 1984; 130:1166–9.
21. DeGowin RL. A review of the therapeutic and hemolylic effects of dapsone. Arch Intern Med 1967; 120:242–8.
22. Graham WR Jr. Adverse effects of dapsone. Int J Dermatol 1975; 14:494–500.
23. Grindulis K, McConkey B. Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin. J Rheumatol 1984; 11:776–8.
24. Glader BE, Conrad ME. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS. J Lab Clin Med 1973; 81:267–72.
25. Rasbridge MR, Scott GL. The haemolytic action of dapsone: the effect on red-cell glycolysis. Br J Haematol 1973; 24:169–81.
26. Finch CA. Methemoglobinemia and sulfhemoglobinemia. N Fngl J Med 1948; 239:470–8.
27. Kramer PA, Glader BE, Li TK. Mechanism of methemoglobin formation by diphenylsulfones: effect of 4-amuio-4′-hydroxyaminodiphenylsulfone and other p-substiluted derivatives. Biochem Pharmacol 1972; 21:1265–74.
28. Cucinell SA, Isrili ZH, Dayton PG. Microsomal N-oxidation of dapsone as a cause of methemoglobin formation in human red cells. Am J Trop Med Hyg 1972; 21:322–31.